Evidence map›Paper›PMID 28279692›Full record

ArticleReproductive toxicology (Elmsford, N.Y.)2017

Ovarian effects of prenatal exposure to benzo[a]pyrene: Roles of embryonic and maternal glutathione status.

Ulrike Luderer, Meagan B Myers, Malathi Banda, Karen L McKim, Laura Ortiz, Barbara L Parsons

Open access · greenAbstract read
In one paragraph

Article in Reproductive toxicology (Elmsford, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ulrike LudererDivision of Occupational and Environmental Medicine, Department of Medicine, University of California Irvine, Irvine, CA 92617, United States; Department of Developmental and Cell Biology, UC Irvine, Irvine, CA 92617, United States; Program in Public Health, UC Irvine, Irvine, CA 92617, United States. Electronic address: uluderer@uci.edu.
Meagan B MyersU.S. Food, Drug Administration, Division of Genetic, Reproductive Toxicology, National Center for Toxicological Research, Jefferson, AR, United States.
Malathi BandaU.S. Food, Drug Administration, Division of Genetic, Reproductive Toxicology, National Center for Toxicological Research, Jefferson, AR, United States. Electronic address: Malathi.Banda@covance.com.
Karen L McKimU.S. Food, Drug Administration, Division of Genetic, Reproductive Toxicology, National Center for Toxicological Research, Jefferson, AR, United States.
Laura OrtizDivision of Occupational and Environmental Medicine, Department of Medicine, University of California Irvine, Irvine, CA 92617, United States.
Barbara L ParsonsU.S. Food, Drug Administration, Division of Genetic, Reproductive Toxicology, National Center for Toxicological Research, Jefferson, AR, United States.
National Center for Toxicological Research · USUC Irvine Health · USUniversity of California, Irvine · US

Funding

Univ.of Calif., Irvine Cancer Center Support GrantP30CA062203 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Christine Hui · 1994 to 2026
$57.9M
Developmental Gene-Environment Interactions and Premature Ovarian FailureR01ES020454 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI LUDERER, ULRIKE · 2012 to 2021
$4.7M
NCI NIH HHS P30 CA062203NIEHS NIH HHS R01 ES020454
6 · The paper itself

Abstract

Females deficient in the glutamate cysteine ligase modifier subunit (Gclm) of the rate-limiting enzyme in glutathione synthesis are more sensitive to ovarian follicle depletion and tumorigenesisby prenatal benzo[a]pyrene (BaP) exposure than Gclm+/+ mice. We investigated effects of prenatal exposure to BaP on reproductive development and ovarian mutations in Kras, a commonly mutated gene in epithelial ovarian tumors. Pregnantmice were dosed from gestational day 6.5 through 15.5 with 2mg/kg/day BaP or vehicle. Puberty onset occurred 5 days earlier in F1 daughters of all Gclm genotypes exposed to BaP compared to controls. Gclm+/- F1 daughters of Gclm+/- mothers and wildtype F1 daughters of wildtype mothers had similar depletion of ovarian follicles following prenatal exposure to BaP, suggesting that maternal Gclm genotype does not modify ovarian effects of prenatal BaP. We observed no BaP treatment or Gclm genotype related differences in ovarian Kras codon 12 mutations in F1 offspring.

Indexed as

Prenatal Exposure Delayed EffectsAnimalsBenzo(a)pyreneFemaleGenes, rasGlutamate-Cysteine LigaseGlutathioneMaternal-Fetal ExchangeMice, Inbred C57BLMice, Mutant StrainsMutationOvaryPregnancySexual MaturationBenzo(a)pyreneGCLM protein, mouseGlutamate-Cysteine LigaseGlutathioneGlutathioneKrasMutationOvarian folliclesPolycyclic aromatic hydrocarbonPuberty

Identifiers

PMID28279692
PMCPMC5422106
OpenAlexW2593041529

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.